Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) related toxicity.
Immune-related adverse events (irAEs) are a major cause of
immune checkpoint inhibitors
МАРКЕРЫ ИММУНОКОМПРОМЕТАЦИИ ПРИ ВОЗДЕЙСТВИИ КСЕНОБИОТИКОВПисарев, В.М.,
Тутельян, А.В.,
Хасанова, Г.М.,
Pisarev, V.M.,
Tutelyan, A.V.,
Khasanova, G.M. (2018) is carried out. Biomarkers of immunocompromentation of congenital and adaptive
immunity are
proposed.
СОСТОЯНИЕ ИММУНИТЕТА У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 1 И 2 ТИПОВ ПРИ ПИЕЛОНЕФРИТЕЧакрян, С.А.,
Тимербулатов, В.М.,
Моргунова, Т.В.,
Алибаева, Г.Ф.,
Chakryan, S.A.,
Timerbulatov, V.M.,
Morugova, T.V.,
Alibaeva, G.F. (2010) Aim. To elucidate changes in the
immunity status of patients with type 1 and 2 diabetes mellitus
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC,
immune checkpoint